MX9604540A - Derivados de aminoestilbazol y su farmaco. - Google Patents

Derivados de aminoestilbazol y su farmaco.

Info

Publication number
MX9604540A
MX9604540A MX9604540A MX9604540A MX9604540A MX 9604540 A MX9604540 A MX 9604540A MX 9604540 A MX9604540 A MX 9604540A MX 9604540 A MX9604540 A MX 9604540A MX 9604540 A MX9604540 A MX 9604540A
Authority
MX
Mexico
Prior art keywords
hydrogen
medicine
represent
ring
aminostilbazole
Prior art date
Application number
MX9604540A
Other languages
English (en)
Other versions
MXPA96004540A (es
Inventor
Hiroyoshi Hidaka
Akira Matsuura
Masato Matsuda
Original Assignee
Nippon Shinyaku Co Ltd
Hiroyoshi Hidaka
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nippon Shinyaku Co Ltd, Hiroyoshi Hidaka filed Critical Nippon Shinyaku Co Ltd
Publication of MX9604540A publication Critical patent/MX9604540A/es
Publication of MXPA96004540A publication Critical patent/MXPA96004540A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/36—Radicals substituted by singly-bound nitrogen atoms
    • C07D213/42—Radicals substituted by singly-bound nitrogen atoms having hetero atoms attached to the substituent nitrogen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C07D213/76—Nitrogen atoms to which a second hetero atom is attached
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/89—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members with hetero atoms directly attached to the ring nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/26—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/10—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D241/12—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cephalosporin Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

La invencion se relaciona con un derivado aminoestilbazol de la siguiente formula o un hidrato del mismo, o su sal. En la que R1 y R2 cada una representan hidrogeno, etc., R3, R4, R13 y R14 cada uno representan hidrogeno, acilo de C1-3, halogeno, hidroxi, etc., R5 representa hidrogeno o alquilo de C1-3 hidroxi sustituido, etc.; R6 representa bencensulfonilo sustituido por alcoxi de C1-3, etc.; el anillo y representa fenilo, etc.; el anillo Z representa 4-piridilo, su oxido etc. El compuesto es util para el tratamiento de varios tumores malignos.
MXPA/A/1996/004540A 1994-04-06 1996-10-02 Derivado aminoestilbazol y su farmaco MXPA96004540A (es)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP6/068252 1994-04-06
JP6825294 1994-04-06
JP6/68252 1994-04-06
PCT/JP1995/000658 WO1995027699A1 (fr) 1994-04-06 1995-04-05 Derive d'aminostilbazole et medicament

Publications (2)

Publication Number Publication Date
MX9604540A true MX9604540A (es) 1997-09-30
MXPA96004540A MXPA96004540A (es) 1998-07-03

Family

ID=

Also Published As

Publication number Publication date
EP0754682A4 (en) 1998-03-04
ES2165911T3 (es) 2002-04-01
EP0754682B9 (en) 2003-09-17
CN1145066A (zh) 1997-03-12
CA2187214A1 (en) 1995-10-19
EP0754682A1 (en) 1997-01-22
TW308586B (es) 1997-06-21
JP3080405B2 (ja) 2000-08-28
DE69523298T2 (de) 2002-06-27
DK0754682T3 (da) 2002-02-04
US5972976A (en) 1999-10-26
KR970702253A (ko) 1997-05-13
ATE207057T1 (de) 2001-11-15
WO1995027699A1 (fr) 1995-10-19
CA2187214C (en) 2002-03-12
EP0754682B1 (en) 2001-10-17
RU2138482C1 (ru) 1999-09-27
DE69523298D1 (de) 2001-11-22
PT754682E (pt) 2002-03-28
KR100293867B1 (ko) 2001-09-17
CN1053658C (zh) 2000-06-21

Similar Documents

Publication Publication Date Title
DE69831937D1 (de) Bicyclische protein-farnesyl-transferase inhibitoren
ES8501368A1 (es) Procedimiento para preparar derivados de n-fenil-benzamida
MY125942A (en) Aminoalkoxy carbazoles for the treatment of cns diseases
MY131193A (en) 7-(2-aminoethyl)-benzothiazolones
ES2010071A6 (es) Procedimiento para preparar derivados de isoquinolina.
NZ518637A (en) Bicyclic imidazo-3-yl amine derivatives substituted on the 6-membered ring
IT1315267B1 (it) Derivati di 2-(1h-indol-3-il)-2-oxo-acetammidi ad attivita'antitumorale
ATE207057T1 (de) Aminostilbazolderivate und medikament
MX9806246A (es) PIPERIDINAS NOVEDOSAS DERIVADAS DE 1-/(PIPERAZIN-1-IL)ARIL-(OXI/AMINO)CARBONIL(4-ARIL-PIPERIDIN A COMO ANTAGONISTAS SELECTIVOS DEL RECEPTOR 5-HT-1D- beta-.
MX9800412A (es) Preparacion de 3-hidroxipirazoles n-substituidos.
GB9300195D0 (en) Piperazine derivatives
DE69622260T2 (de) 2-arylbenzazole verbindungen
NO900697L (no) Fremgangsmaate for fremstilling av terapeutisk aktive acetamid-derivater.
EP0774462A4 (en) HETEROCYCLIC COMPOUND
GR3029471T3 (en) 2-substituted quinolines for treating leishmanioses.
HU9601587D0 (en) Antracycline derivatives
PL331347A1 (en) Derivatives of n-benzene sulphonyl-l-proline
ES467069A1 (es) Un procedimiento para la preparacion de nuevos derivados de 1-3-bencenodimetanol
TW350838B (en) Quinoline derivatives
PL335545A1 (en) Application of 2,3,4,5-tetrahydro-1h-3-benzazepines in production of a pharmaceutic composition useful in treating sleep disorders
ZA941334B (en) Amide derivative .
MX9800925A (es) Uso de derivados de adamantano para tratar enfermedades del oido interno.
TW257758B (en) Piperazine derivatives (1)
HUT49865A (en) Process for producing new 2,3-thiomorpholinedione-2-oximes